Oct 17 |
Does Johnson & Johnson (NYSE:JNJ) Have A Healthy Balance Sheet?
|
Oct 17 |
Johnson & Johnson price target raised to $181 from $178 at RBC Capital
|
Oct 17 |
This Magnificent Dividend Stock Is as Healthy as It Gets
|
Oct 16 |
J&J trims neuroscience pipeline – seltorexant in Alzheimer’s disease dropped
|
Oct 16 |
Johnson & Johnson's MedTech Challenges Loom Amid Chinese Market Pressures And Orthopedics Overhaul, Analysts Say
|
Oct 16 |
J&J makes surgical robotic moves with Ottava FDA IDE application
|
Oct 16 |
Stock Market News for Oct 16, 2024
|
Oct 16 |
Johnson & Johnson Beats Wall Street Estimates. Is It Time to Buy, Sell, or Hold?
|
Oct 16 |
Johnson & Johnson (JNJ) Q3 2024 Earnings Call Highlights: Strong Sales Growth Amidst ...
|
Oct 16 |
Q3 2024 Johnson & Johnson Earnings Call
|